-
2023-505261-84-00
5
2020-10-06
Primary high risk leiomyosarcoma or liposarcoma of retroperitoneal spa
-
2024-519930-22-00
4
2026-05-18
Systemic Lupus Erythematosus (SLE) With or Without Active Lupus Nephri
-
2025-523602-33-00
9
2026-05-13
Advanced or unresectable Hepatocellular Carcinoma (HCC)
-
2024-517337-41-00
5
2026-05-12
Completely resected Stage IIA-IIIB (N2) KRAS G12C mutated NSCLC
-
2024-516993-31-00
5
2026-05-11
Renal Cell Carcinoma
-
2023-509628-16-00
5
2026-05-07
Small Cell Lung Cancer (SCLC)
-
2025-523123-22-00
5
2026-05-07
Chronic Kidney Disease
-
2025-523552-31-00
5
2026-05-07
Systemic Lupus Erythematosus
-
2025-523717-29-00
5
2026-04-28
HFpEF or HFmrEF and obesity
-
2025-523804-62-00
5
2026-04-28
Obesity
-
2025-524136-19-00
1
2026-04-28
Selected Advanced or Metastatic Solid Tumors
-
2024-520014-22-00
5
2026-04-22
Locally advanced/metastatic urothelial carcinoma
-
2024-519304-28-00
5
2026-04-20
Multiple Sclerosis
-
2025-523553-34-00
1
2026-04-15
Advanced and Metastatic Solid tumors
-
2025-523085-24-00
5
2026-04-13
Biliary Tract Cancer
-
2025-522403-17-00
5
2026-04-10
Nummular Dermatitis
-
2024-520101-39-00
5
2026-04-01
TROP2 NMR-positive advanced or metastatic non-squamous non-small cell
-
2025-522338-30-00
4
2026-03-31
Ulcerative Colitis
-
2025-522674-36-00
5
2026-03-24
Metabolic Dysfunction-Associated Steatotic Liver Disease
-
2025-523091-23-00
4
2026-03-24
Peripheral anti-MAG neuropathy, waldenstrom macroglobulinemia, margina
-
2025-521036-11-00
5
2026-03-23
Immune system disseases
-
2024-520026-11-00
7
2026-03-19
Metastatic Prostate Cancer
-
2024-518210-81-00
5
2026-03-18
Advanced Hepatocellular Carcinoma
-
2025-521319-38-00
4
2026-03-11
metastatic colorectal cancer